Professor Drach is a specialist in oncology with a PhD from the Medical University of Vienna. He has experience in research, internal medicine, hematologic oncology, nutrition, and lifestyle in cancer. He is the Director of the Josefstadt Private Clinic in Vienna and a member of the Board of Directors of the Austrian Society of Hematology and Oncology. He has published more than 120 scientific papers and given more than 200 lectures/presentations.
Read moreProfessor Drach is a specialist in oncology with a PhD from the Medical University of Vienna. He has experience in research, internal medicine, hematologic oncology, nutrition, and lifestyle in cancer. He is the Director of the Josefstadt Private Clinic in Vienna and a member of the Board of Directors of the Austrian Society of Hematology and Oncology. He has published more than 120 scientific papers and given more than 200 lectures/presentations.
| Doctor's visit | price on request |
| Chemotherapy | $985 |
| Doctor's visit | price on request |
| Removal of meningioma | $22744.72 |
| Esophagectomy | $3282 - $4376 |
| Breast cancer surgery | $11372.36 - $15921.3 |
Specializations
Brain Tumors
Aneurysm Surgery
Pituitary Surgery
Spine Surgery
Waist neck and back hernias
Spine Tumors
Spinal Fractures
Peripheral Nerve Surgery
Read more
Specializations
Brain Tumors
Aneurysm Surgery
Pituitary Surgery
Spine Surgery
Waist neck and back hernias
Spine Tumors
Spinal Fractures
Peripheral Nerve Surgery
| Doctor's visit | price on request |
| Herniated disc surgery | $13784 |
| Knee replacement | $7650 - $8350 |
AREAS OF INTEREST
Education and Specialization
Experience
Professional Memberships
Turkish Society of Medical Oncology
Education and Training:
Areas of Expertise:
Achievements and Awards:
AREAS OF INTEREST
Education and Specialization
Experience
Professional Memberships
Turkish Society of Medical Oncology
Education and Training:
Areas of Expertise:
Achievements and Awards:
Trauma and Emergency Orthopedics: Dr. Aydın is an expert in managing traumatic injuries, including fractures, dislocations, and soft tissue injuries. His approach is focused on minimizing recovery time and ensuring the best possible functional outcomes for patients.
Joint Replacement Surgery: Specializing in hip, knee, and shoulder replacement surgeries, he has performed numerous successful joint replacements, offering patients relief from chronic pain and enhanced mobility.
Sports Injuries: Dr. Aydın has an in-depth understanding of sports-related injuries, including ligament tears, tendon ruptures, and cartilage damage. He employs both conservative and surgical techniques to help athletes recover and return to their active lifestyles.
Spine Surgery: His experience extends to treating various spine conditions, such as degenerative diseases, herniated discs, and spinal deformities. He uses minimally invasive techniques whenever possible to reduce recovery times and improve surgical outcomes.
Pediatric Orthopedics: Dr. Aydın also has expertise in treating musculoskeletal conditions in children, such as congenital deformities, growth plate injuries, and scoliosis.
Arthroscopy: Skilled in minimally invasive arthroscopic surgery, Dr. Aydın can diagnose and treat conditions affecting joints, including the knee, shoulder, and ankle, with reduced scarring and quicker recovery.
Complex Trauma and Reconstruction: With a focus on treating complex fractures and trauma cases, he is skilled in using advanced surgical techniques to restore function and structure to severely injured bones and soft tissues.
Dr. Aydın’s position as an Associate Professor underscores his dedication to advancing the field through both teaching and research. He actively contributes to medical literature, presenting innovative findings and new treatment methodologies in orthopedics and traumatology. His research interests include improving patient outcomes in fracture healing, developing better surgical techniques, and exploring the use of regenerative medicine in orthopedic care.
Dr. Aydın takes a patient-centered approach, tailoring treatment plans to meet the unique needs of each individual. He emphasizes early intervention, advanced diagnostic tools, and personalized rehabilitation strategies to ensure optimal recovery.
Through his extensive knowledge and experience in orthopedics and traumatology, Dr. Murat Aydın has earned a reputation for excellence in patient care, making him a highly respected figure in his field.
Read moreTrauma and Emergency Orthopedics: Dr. Aydın is an expert in managing traumatic injuries, including fractures, dislocations, and soft tissue injuries. His approach is focused on minimizing recovery time and ensuring the best possible functional outcomes for patients.
Joint Replacement Surgery: Specializing in hip, knee, and shoulder replacement surgeries, he has performed numerous successful joint replacements, offering patients relief from chronic pain and enhanced mobility.
Sports Injuries: Dr. Aydın has an in-depth understanding of sports-related injuries, including ligament tears, tendon ruptures, and cartilage damage. He employs both conservative and surgical techniques to help athletes recover and return to their active lifestyles.
Spine Surgery: His experience extends to treating various spine conditions, such as degenerative diseases, herniated discs, and spinal deformities. He uses minimally invasive techniques whenever possible to reduce recovery times and improve surgical outcomes.
Pediatric Orthopedics: Dr. Aydın also has expertise in treating musculoskeletal conditions in children, such as congenital deformities, growth plate injuries, and scoliosis.
Arthroscopy: Skilled in minimally invasive arthroscopic surgery, Dr. Aydın can diagnose and treat conditions affecting joints, including the knee, shoulder, and ankle, with reduced scarring and quicker recovery.
Complex Trauma and Reconstruction: With a focus on treating complex fractures and trauma cases, he is skilled in using advanced surgical techniques to restore function and structure to severely injured bones and soft tissues.
Dr. Aydın’s position as an Associate Professor underscores his dedication to advancing the field through both teaching and research. He actively contributes to medical literature, presenting innovative findings and new treatment methodologies in orthopedics and traumatology. His research interests include improving patient outcomes in fracture healing, developing better surgical techniques, and exploring the use of regenerative medicine in orthopedic care.
Dr. Aydın takes a patient-centered approach, tailoring treatment plans to meet the unique needs of each individual. He emphasizes early intervention, advanced diagnostic tools, and personalized rehabilitation strategies to ensure optimal recovery.
Through his extensive knowledge and experience in orthopedics and traumatology, Dr. Murat Aydın has earned a reputation for excellence in patient care, making him a highly respected figure in his field.
| Doctor's visit | price on request |
| Herniated disc surgery | $13784 |
| Knee replacement | $7650 - $8350 |
The former chief physician of the Kaposi Mór Teaching Hospital, he is currently a staff member of Neurosurgery at the Péterfy S. Hospital.
At the appointment, we accept patients from the age of 6.
Memberships
Academic degree
PhD, private university teacher
International experience
National Hospitals for Nervous Diseases, London, UK, Zurich, Würzburg, Mainz, Magdeburg, Al Ain (UAE)
Read moreThe former chief physician of the Kaposi Mór Teaching Hospital, he is currently a staff member of Neurosurgery at the Péterfy S. Hospital.
At the appointment, we accept patients from the age of 6.
Memberships
Academic degree
PhD, private university teacher
International experience
National Hospitals for Nervous Diseases, London, UK, Zurich, Würzburg, Mainz, Magdeburg, Al Ain (UAE)
Professional experience
Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.
Membership in scientific societies
National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)
President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).
Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).
Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).
Research and Teaching
Principal investigator of 100 national and international clinical trials.
7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).
10 projects from private foundations, received on a competitive basis (7 as principal investigator).
He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).
His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.
Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.
Education :
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Read moreProfessional experience
Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.
Membership in scientific societies
National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)
President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).
Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).
Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).
Research and Teaching
Principal investigator of 100 national and international clinical trials.
7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).
10 projects from private foundations, received on a competitive basis (7 as principal investigator).
He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).
His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.
Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.
Education :
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
| Doctor's visit | price on request |
| Herniated disc surgery | $11144.91 |
| Transurethral resection of the prostate (TURP) | $1747.93 |
| from a related donor | $179150 |
Professor Dihné is a true master in understanding the subtle mechanisms of the nervous sy. His professionalism is manifested in his profound knowledge of anatomy and physiology, as well as in his ability to accurately identify and effectively treat diseases that can affect both the physical and psychological state of the patient. Professor Dihné listens carefully to everyone, creating an atmosphere of trust, and based on thorough examinations and analyses, develops an individualized treatment plan. He not only has knowledge in his hands, but also the ability to feel and understand how to restore harmony in a person's body and mind, giving them back their quality of life.
Membership in societies and awards:
German Society of Physicians.
Research Award of the Christian and Claudia Hempel Foundation for outstanding research in the field of clinical research.
Author of numerous publications in leading medical journals in Germany and Europe.
Specialization:
Work experience:
2001-2004: Training at the Centre for Molecular Neurobiology in Hamburg.
2004-2011: Training at the Neurological University Clinic Düsseldorf.
2011-2013: Training at the Neurological University Hospital Tübingen and the Hertie Institute for Clinical Brain Research.
Professor Dihne began his scientific career at the University of Düsseldorf.
2013-2023 Professor Dihne successfully headed the Department of Neurology at the St. Lukas Klinik Solingen for 10 years.
Since 2024: Chief Physician at the Department of Neurology at the Academic Hospital Solingen.
Read more
Professor Dihné is a true master in understanding the subtle mechanisms of the nervous sy. His professionalism is manifested in his profound knowledge of anatomy and physiology, as well as in his ability to accurately identify and effectively treat diseases that can affect both the physical and psychological state of the patient. Professor Dihné listens carefully to everyone, creating an atmosphere of trust, and based on thorough examinations and analyses, develops an individualized treatment plan. He not only has knowledge in his hands, but also the ability to feel and understand how to restore harmony in a person's body and mind, giving them back their quality of life.
Membership in societies and awards:
German Society of Physicians.
Research Award of the Christian and Claudia Hempel Foundation for outstanding research in the field of clinical research.
Author of numerous publications in leading medical journals in Germany and Europe.
Specialization:
Work experience:
2001-2004: Training at the Centre for Molecular Neurobiology in Hamburg.
2004-2011: Training at the Neurological University Clinic Düsseldorf.
2011-2013: Training at the Neurological University Hospital Tübingen and the Hertie Institute for Clinical Brain Research.
Professor Dihne began his scientific career at the University of Düsseldorf.
2013-2023 Professor Dihne successfully headed the Department of Neurology at the St. Lukas Klinik Solingen for 10 years.
Since 2024: Chief Physician at the Department of Neurology at the Academic Hospital Solingen.
| Doctor's visit | price on request |
| Removal of meningioma | $22744.72 |
| Esophagectomy | $3282 - $4376 |
| Breast cancer surgery | $11372.36 - $15921.3 |
Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology
Education:
Professional Experience:
Clinical Trials, Courses, Certifications:
Clinical Trials:
Courses:
Certifications:
Memberships:
Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology
Education:
Professional Experience:
Clinical Trials, Courses, Certifications:
Clinical Trials:
Courses:
Certifications:
Memberships:
| Doctor's visit | price on request |
| Herniated disc surgery | $8752 - $9846 |
| Discectomy | $6345 |
| Surgical treatment of scoliosis | $10750 - $11750 |
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Syic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Syic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Read more
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Syic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Syic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
| Doctor's visit | price on request |
| Trachelectomy (cervicectomy) | $2500 - $3500 |
| Whipple surgery | $18000 - $25000 |
| Surgical treatment of scoliosis | $18000 - $25000 |
| Doctor's visit | price on request |
| Complex treatment of thyroid cancer | $200 |
| Doctor's visit | price on request |
| Removal of meningioma | $22744.72 |
| Esophagectomy | $3282 - $4376 |
| Breast cancer surgery | $11372.36 - $15921.3 |
| Doctor's visit | price on request |
| Complex treatment of thyroid cancer | $200 |
| Doctor's visit | price on request |
| Targeted therapy | $750 - $2500 |
| Hysterectomy (uterus removal) | $4500 |
| Prostatectomy | $8500 |
Doctor of Medicine: Istanbul University Cerrahpaşa Faculty of Medicine (1987-1993)
Neurology Specialist: Osmangazi University Faculty of Medicine (1997-2001)
Stroke Fellow: University of Calgary, Canada (2008-2009)
Assistant Professor: Trakya University Faculty of Medicine (2001-2006)
Associate Professor: Trakya University Faculty of Medicine (2006-2010), Bezmialem Faculty of Medicine (2010-2012)
Professor: Bezmialem Faculty of Medicine (2012-2017), Memorial Hizmet Hospital (2017-2019, 2021-2023)
Interventional Neurologist: King Hamad University Hospital, Bahrain (2019-2021)
Consultant Neurologist: Salmaniya Medical Complex, Bahrain (2023-2024)
Between 2008-2009, I worked as a stroke fellow at the University of Calgary Stroke Program for 1 year.
During my tenure at Bezmialem Vakıf University, I received interventional neurology training from Prof. Dr. Ömer Göktekin.
2019-2021 I worked as an interventional neurologist at Arabian Gulf University and King Hamad University Hospital in Bahrain.
I worked as a consultant neurologist at Salmaniya Medical Complex in Bahrain between 2023-2024.
Doctor of Medicine: Istanbul University Cerrahpaşa Faculty of Medicine (1987-1993)
Neurology Specialist: Osmangazi University Faculty of Medicine (1997-2001)
Stroke Fellow: University of Calgary, Canada (2008-2009)
Assistant Professor: Trakya University Faculty of Medicine (2001-2006)
Associate Professor: Trakya University Faculty of Medicine (2006-2010), Bezmialem Faculty of Medicine (2010-2012)
Professor: Bezmialem Faculty of Medicine (2012-2017), Memorial Hizmet Hospital (2017-2019, 2021-2023)
Interventional Neurologist: King Hamad University Hospital, Bahrain (2019-2021)
Consultant Neurologist: Salmaniya Medical Complex, Bahrain (2023-2024)
Between 2008-2009, I worked as a stroke fellow at the University of Calgary Stroke Program for 1 year.
During my tenure at Bezmialem Vakıf University, I received interventional neurology training from Prof. Dr. Ömer Göktekin.
2019-2021 I worked as an interventional neurologist at Arabian Gulf University and King Hamad University Hospital in Bahrain.
I worked as a consultant neurologist at Salmaniya Medical Complex in Bahrain between 2023-2024.
| Doctor's visit | price on request |
| Complex treatment of thyroid cancer | $200 |
Professor Markus Dukes is a specialist in diagnostic radiology and minimally invasive therapy.
Marcus Dukes is one of the first physicians to perform minimally invasive microwave ablation of liver and lung tumors under CT guidance.
The professor heads the first and only MRI-guided FUS ablation center in the Rhine-Main region. In most cases, the procedure allows avoiding surgical intervention. Patients of the center have access to ablation for prostate cancer, bone and liver metastases, benign tumors, and treatment of uterine fibroids without surgery.
Professor Markus Dukes is a specialist in diagnostic radiology and minimally invasive therapy.
Marcus Dukes is one of the first physicians to perform minimally invasive microwave ablation of liver and lung tumors under CT guidance.
The professor heads the first and only MRI-guided FUS ablation center in the Rhine-Main region. In most cases, the procedure allows avoiding surgical intervention. Patients of the center have access to ablation for prostate cancer, bone and liver metastases, benign tumors, and treatment of uterine fibroids without surgery.
Istanbul University Cerrahpaşa Faculty of Medicine, 2002
Istanbul Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine, 2010
Istanbul University Oncology Institute (Çapa), Medical Oncology, 2015
Medipol University Faculty of Medicine, Phytotherapy Education, 2018
University of Health Sciences, Vocational School of Health, Molecular Oncology, PhD Program, PhD, 2023
University Hospital, Newark, New Jersey, USA, Observer (2003-2004)
Siirt State Hospital, Internal Medicine (2010-2011)
Siirt State Hospital, Medical Oncology (2015)
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Medical Oncology (2015-2018)
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Medical Oncology, (Professor Doctor) (2018-Present)
Forensic Medicine 3. Specialization Board, Medical Oncology, Full Member (2019-Present)
Liv Hospital, Ulus, Park-time, Medical Oncology (2020-2022)
Şişli Kolan International Hospital, Park-time, Medical Oncology (2022-2023)
2010-YDUS (Subspecialty Examination) 14th place in Turkey
2014- Oncology Institute Days Best Poster Award
2015- Turkish Medical Oncology Society Board Exam Qualification
2015- ESMO (European Society for Medical Oncology) Board Exam Qualification
Istanbul University Cerrahpaşa Faculty of Medicine, 2002
Istanbul Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine, 2010
Istanbul University Oncology Institute (Çapa), Medical Oncology, 2015
Medipol University Faculty of Medicine, Phytotherapy Education, 2018
University of Health Sciences, Vocational School of Health, Molecular Oncology, PhD Program, PhD, 2023
University Hospital, Newark, New Jersey, USA, Observer (2003-2004)
Siirt State Hospital, Internal Medicine (2010-2011)
Siirt State Hospital, Medical Oncology (2015)
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Medical Oncology (2015-2018)
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Medical Oncology, (Professor Doctor) (2018-Present)
Forensic Medicine 3. Specialization Board, Medical Oncology, Full Member (2019-Present)
Liv Hospital, Ulus, Park-time, Medical Oncology (2020-2022)
Şişli Kolan International Hospital, Park-time, Medical Oncology (2022-2023)
2010-YDUS (Subspecialty Examination) 14th place in Turkey
2014- Oncology Institute Days Best Poster Award
2015- Turkish Medical Oncology Society Board Exam Qualification
2015- ESMO (European Society for Medical Oncology) Board Exam Qualification
| Doctor's visit | price on request |
| Complex treatment of thyroid cancer | $200 |
Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015
MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022
Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)
Medical Intrests
Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015
MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022
Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)
Medical Intrests
| Doctor's visit | price on request |
| Complex treatment of thyroid cancer | $200 |
| Doctor's visit | price on request |
| Targeted therapy | $750 - $2500 |
| Hysterectomy (uterus removal) | $4500 |
| Prostatectomy | $8500 |
Doctor: Kilis Merkez No. 1 Health Center, 2006-2008
Assistant Doctor: Mersin University Faculty of Medicine, 2009-2013
Specialist Doctor: Bingöl Genç State Hospital, 2013-2014
Minor Assistant: Akdeniz University Faculty of Medicine, 2014-2017
Minor Specialist: Erzurum Regional Training and Research Hospital, 2017-2018
Subspecialist: Gaziosmanpaşa Training and Research Hospital, 2018-2020
Attending Specialist: Başakşehir Çam and Sakura City Hospital, 2020-2022
Associate Professor: Başakşehir Çam and Sakura City Hospital, 2023
Associate Professor: Istinye University Medicalpark Gaziosmanpaşa Hospital, 2023-2024
Turkish Pediatric Society
Turkish Society for Pediatric Gastroenterology Hepatology and Nutrition
ESPGHAN - European Society for Pediatric Gastroenterology Hepatology and Nutrition.
Doctor: Kilis Merkez No. 1 Health Center, 2006-2008
Assistant Doctor: Mersin University Faculty of Medicine, 2009-2013
Specialist Doctor: Bingöl Genç State Hospital, 2013-2014
Minor Assistant: Akdeniz University Faculty of Medicine, 2014-2017
Minor Specialist: Erzurum Regional Training and Research Hospital, 2017-2018
Subspecialist: Gaziosmanpaşa Training and Research Hospital, 2018-2020
Attending Specialist: Başakşehir Çam and Sakura City Hospital, 2020-2022
Associate Professor: Başakşehir Çam and Sakura City Hospital, 2023
Associate Professor: Istinye University Medicalpark Gaziosmanpaşa Hospital, 2023-2024
Turkish Pediatric Society
Turkish Society for Pediatric Gastroenterology Hepatology and Nutrition
ESPGHAN - European Society for Pediatric Gastroenterology Hepatology and Nutrition.
| Doctor's visit | price on request |
| Complex treatment of thyroid cancer | $200 |